SURVEY ON THE SITUATION OF CANCER AT INTERNAL MEDICINE DEPARTMENT A1, THONG NHAT HOSPITAL IN THE PERIOD OF 2019 – 2023

Lê Thị Mai Hương 1 , , Lâm Thị Hiền 1 , Trương Văn Trị 1 , Lưu Thanh Bình 1
1 Thong Nhat Hospital
* Corresponding author:

Article Information

Metrics
Downloads: 0 Views: 0
Published
2025-06-15
Section
Original Paper
Categories

Download Article

How to Cite

1.
Thị Mai Hương L, Thị Hiền L, Văn Trị T, Thanh Bình L. SURVEY ON THE SITUATION OF CANCER AT INTERNAL MEDICINE DEPARTMENT A1, THONG NHAT HOSPITAL IN THE PERIOD OF 2019 – 2023. JHA [Internet]. Vietnam; 2025 Jun. 15 [cited 2025 Jun. 23];1(2):119–123. https://tcsuckhoelaohoa.vn/bvtn/article/view/48 doi: 10.63947/bvtn.v1i2.17
Loading...
Loading citation...

Abstract

To survey the prevalence of cancer types, disease stages, and treatment methods in Department A1, Thong Nhat Hospital, from 2019 to 2023, and to evaluate initial cancer treatment outcomes. A cross-sectional descriptive study was conducted on 192 cancer patients admitted for inpatient and outpatient treatment in Department A1 from January 2019 to December 2023. Prostate cancer (29.2%) and colorectal cancer (22.4%) were the most common types. In terms of treatment, 68.2% of patients received two or more treatment modalities, with surgery and chemotherapy being the most frequently applied methods. The proportion of patients receiving late treatment (stage III-IV) was low (11.5%), with 52.6% of patients stable after treatment and a mortality rate of 20.8%. The study highlights the highest prevalence in prostate and colorectal cancer. Multimodal treatment plays a crucial role in stabilizing patients, with a low rate of late treatment and positive treatment outcomes.

Keywords

Cancer multimodal treatment late-stage treatment

References

  1. Bộ Y t. Hướng dẫn chẩn đoán và điều trị một số bệnh ung bướu. Quyết định số1514/QĐ-BYT. 2020.
  2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a cancer journal for clinicians. 2021;71(3):209-49. Epub 2021/02/05. doi: 10.3322/caac.21660. PubMed PMID: 33538338.
  3. Tô Minh N, Châu Tấn Đ, Lâm Thanh H, Võ Huỳnh N. Kết quả ghi nhận ung thư quần thể tại Cà Mau giai đoạn 2010 -2013. Đề tài nghiên cứu khoa học cấp tỉnh. 2016.
  4. Bộ Y t. Hướng dẫn sử dụng bảng phân loại thống kê quốc tế về bệnh tật và các vấn đề sức khỏe có liên quan phiên bản lần thứ10 (ICD-10), tập 1. Hà Nội: Nhà xuất bản Y học; 2015.
  5. American Joint Committee on C. Cancer Staging Systems. 2022.
  6. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA: a cancer journal for clinicians. 2021;71(1):7-33. Epub 2021/01/13. doi: 10.3322/caac.21654. PubMed PMID: 33433946.
  7. Fokas E, Glynne-Jones R, Appelt A, Beets-Tan R, Beets G, Haustermans K, et al. Outcome measures in multimodal rectal cancer trials. The Lancet Oncology. 2020;21(5):e252-e64. doi: 10.1016/S1470-2045(20)30024-3.
  8. Wilkinson N, Zuckerman R. Surgical Oncology for the General Surgeon. The Surgical clinics of North America. 2020;100(3):xv-xvi. Epub 2020/05/14. doi: 10.1016/j.suc.2020.04.001. PubMed PMID: 32402310.
  9. Tsimberidou AM. Targeted therapy in cancer. Cancer chemotherapy and pharmacology. 2015;76(6):1113-32. Epub 2015/09/24. doi: 10.1007/s00280-015-2861-1. PubMed PMID: 26391154; PubMed Central PMCID: PMCPMC4998041.
  10. Rajagopal PS, Nipp RD, Selvaggi KJ. Chemotherapy for advanced cancers. Annals of Palliative Medicine. 2014;3(3):203-28.
  11. Min Y, Liu Z, Huang R, Li R, Jin J, Wei Z, et al. Survival outcomes following treatment delays among patients with early-stage female cancers: a nationwide study. Journal of translational medicine. 2022;20(1):560. Epub 2022/12/04. doi: 10.1186/s12967-022-03719-7. PubMed PMID: 36463201; PubMed Central PMCID: PMCPMC9719121.

License

© 2025 Journal of Health and Aging - Thong Nhat Hospital